Minireviews
Copyright ©The Author(s) 2023.
World J Clin Oncol. Sep 24, 2023; 14(9): 335-342
Published online Sep 24, 2023. doi: 10.5306/wjco.v14.i9.335
Table 1 Role of pregnane X receptor in the mechanism of drug resistance in breast cancer (including triple-negative breast cancer)
Phase
Resistance-associated proteins associated with PXR
Resistance-associated proteins associated with breast cancer
Resistance associated proteins associated with TNBC
Resistance related proteins known to be regulated by PXR in TNBC
Possible regulatory targets of PXR in TNBC (unconfirmed)
Phase ⅠCYP3A4, CYP3A23CYP3A4, CYP3A5CYP3A4CYP3A4CYP2C8
Enzymes metabolismCYP3A11, CYP2B6CYP2C8, CYP2C9CYP4A11
CYPsCYP2C8, CYP2C9CYP2J2, CYP1A1CYP4A22
CYP2C19, CYP1ACYP1B1, CYP17A1CYP2C8
CYP2B9, CYP2C55CYP2B6, CYP2D6CYP1B1
CYP2C19, CYP2S1
CYP4V2, CYP26A1
CYP4A11, CYP4A22
Phase ⅡGSTA1, GSTA2GSTM1, GSTP1GSTP1
Enzymes conjugationGSTA3, GSTM1GSTA1, GSTA2
GSTsGSTM2, GSTM3
GSTM4
UGTsUGT1A1, UGT1A6UGT1A, UGT2B7UGT1A1UGT1A1
UGT1A3, UGT1A4
Phase ⅢABCB1, ABCB2ABCC1, ABCC3ABCC1ABCC1
TtansportersABCC1, ABCC2ABCB1, ABCG2ABCG2ABCG2
ABCsABCC3, ABCC4ABCC11ABCC11
ABCC5, ABCG2